CA2478138A1 - Diagnostic et traitement des maladies respiratoires a partir du cxcl10 - Google Patents

Diagnostic et traitement des maladies respiratoires a partir du cxcl10 Download PDF

Info

Publication number
CA2478138A1
CA2478138A1 CA002478138A CA2478138A CA2478138A1 CA 2478138 A1 CA2478138 A1 CA 2478138A1 CA 002478138 A CA002478138 A CA 002478138A CA 2478138 A CA2478138 A CA 2478138A CA 2478138 A1 CA2478138 A1 CA 2478138A1
Authority
CA
Canada
Prior art keywords
polypeptide
cxcl10
sars
cxcr3
respiratory illness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002478138A
Other languages
English (en)
Inventor
David Kelvin
Desmond Persad
Mark J. Cameron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Health Network
Original Assignee
University Health Network
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health Network filed Critical University Health Network
Priority to CA002478138A priority Critical patent/CA2478138A1/fr
Publication of CA2478138A1 publication Critical patent/CA2478138A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002478138A 2004-08-17 2004-08-17 Diagnostic et traitement des maladies respiratoires a partir du cxcl10 Abandoned CA2478138A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002478138A CA2478138A1 (fr) 2004-08-17 2004-08-17 Diagnostic et traitement des maladies respiratoires a partir du cxcl10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002478138A CA2478138A1 (fr) 2004-08-17 2004-08-17 Diagnostic et traitement des maladies respiratoires a partir du cxcl10

Publications (1)

Publication Number Publication Date
CA2478138A1 true CA2478138A1 (fr) 2006-02-17

Family

ID=35852059

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002478138A Abandoned CA2478138A1 (fr) 2004-08-17 2004-08-17 Diagnostic et traitement des maladies respiratoires a partir du cxcl10

Country Status (1)

Country Link
CA (1) CA2478138A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128612A2 (fr) 2006-09-05 2009-12-02 Hvidovre Hospital Surveillance immunologique sur la base de IP-10
WO2021152595A1 (fr) * 2020-01-29 2021-08-05 Memed Diagnostics Ltd. Méthodes de diagnostic et de classification d'infections virales
CN114656561A (zh) * 2022-03-05 2022-06-24 南京鼓楼医院 一种抗ip-10单克隆抗体及其制备方法和应用

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2128612A2 (fr) 2006-09-05 2009-12-02 Hvidovre Hospital Surveillance immunologique sur la base de IP-10
EP2228651A1 (fr) 2006-09-05 2010-09-15 Hvidovre Hospital Surveillance immunologique sur la base de IP-10
EP2261658A2 (fr) 2006-09-05 2010-12-15 Hvidovre Hospital Diagnostic des infections sur la base de IP-10
WO2021152595A1 (fr) * 2020-01-29 2021-08-05 Memed Diagnostics Ltd. Méthodes de diagnostic et de classification d'infections virales
CN114656561A (zh) * 2022-03-05 2022-06-24 南京鼓楼医院 一种抗ip-10单克隆抗体及其制备方法和应用

Similar Documents

Publication Publication Date Title
US20160368995A1 (en) Identification of cxcr8, a novel chemokine receptor
US7332294B2 (en) CXCL10-based diagnosis and treatment of respiratory illnesses
KR20110014979A (ko) 항바이러스 요법
US12066429B2 (en) Method for inhibiting the expression of inflammation promoting factors
EP2210112B1 (fr) Procédés de diagnostic de l'infection à vih
JP6852926B2 (ja) 細胞遊走調節に関する疾患の予防・治療剤および肺間質の疾患の疾患活動性判定・予後評価
JP2013213774A (ja) 結核検査用バイオマーカー
CA2478138A1 (fr) Diagnostic et traitement des maladies respiratoires a partir du cxcl10
KR101754490B1 (ko) 천식 진단용 마커 조성물, 이를 포함하는 천식 진단용 키트 및 천식 진단을 위한 정보제공방법
EP2795337B1 (fr) Méthodes de criblage pour identifier des composés utiles dans la prévention et/ou le traitement de conditions inflammatoires
US20100298418A1 (en) Assay for measuring plasma FGL-2 and methods and uses thereof
KR101338885B1 (ko) Mgc4504의 용도
JP6565099B2 (ja) 家族性地中海熱のバイオマーカー
US20100100979A1 (en) Biomarker specific for cancer
KR20230064699A (ko) 개에서의 비결핵 항산균의 감염 진단을 위한 숙주 바이오마커 및 이의 이용
JP4819791B2 (ja) リン脂質症の判定方法
Class et al. Patent application title: SCREENING METHODS TO IDENTIFY COMPOUNDS USEFUL IN THE PREVENTION AND/OR TREATMENT OF INFLAMMATORY CONDITIONS Inventors: Reginald Christophe Xavier Brys (Mechelen, BE) Reginald Christophe Xavier Brys (Mechelen, BE) Sonia Dupont (Romainville, FR) Assignees: GALAPAGOS NV
JP2007230910A (ja) Ｖｅｇｆ産生の低減方法
KR20190083801A (ko) 데스모글레인 3의 유전적 변이 및 이의 용도
Finley Molecular basis for kappa-opioid regulation of chemokine receptor function
JP2010111623A (ja) 糖鎖認識受容体の新規用途
EP1287156A2 (fr) Genes stimules par tnf et ifn et utilisations de ceux-ci
WO2009049406A1 (fr) Diagnostics antiviraux et thérapies afférentes

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead